Can PSMA-Targeted Prostate Biopsy Detect Cancer When MRI-Guided Biopsy is Negative? “Presentation” – Wayne Brisbane
At the 2025 UCSF-UCLA PSMA Conference, Wayne Brisbane presents a phase I trial examining PSMA-targeted prostate biopsy following negative/discordant MRI biopsies. Among 39 patients with SUV max > 3, 41% had Grade Group 2+ cancer. Notably, eleven lesions were completely de novo PSMA findings, with anterior lesions predominating. He suggests PSMA provides valuable “second look” capabilities,…
